Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
IV Vitamin C with Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients: A Forgotten Group
A phase II study of gemcitabine plus cisplatin chemotherapy in patients with muscle-invasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterious DNA damage response DDR gene alterations
A Randomized Phase III Double Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes
Study Type: Supportive Care
Phase: III
NCTID: NCT03757949
Principal Investigator:
Jill Hamilton-Reeves
Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Implementation of Nutrition Education Videos for Patients Undergoing Radical Cystectomy
A Phase II study of TAS-102 in metastatic Platinum and checkpoint inhibitor?resistant bladder cancer
A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients with Unresectable Locally Advanced or Metastatic Urothelial Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 Pembrolizumab in the Treatment of Patients with BCGUnresponsive Non-Muscle Invasive Bladder Cancer
MODERN: An Integrated Phase II/III and Phase III Trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer
Study Type: Treatment
Phase: II/III
NCTID: NCT05987241
Principal Investigator:
Saqib Abbasi